Health

  • October 01, 2025

    Eli Lilly's Drug Suit Slammed As 'Anti-Competitive' Move

    Eli Lilly and Co.'s lawsuit accusing a compounding pharmacy of unlawfully selling untested weight loss drugs should be tossed because the drugmaker didn't show its advertising was deceptive or harmful, the defendant told a Texas federal court this week.

  • October 01, 2025

    Ga. Panel Revives Injury Suit Alleging IV Mixup Against Emory

    The Georgia Court of Appeals on Wednesday revived a woman's lawsuit against a group of registered nurses and Emory Healthcare Inc., in which she alleged her left hand had to be amputated after she was given medication through an IV line there instead of a larger vein.

  • October 01, 2025

    Medtronic Knocks Out Investor Suit Over Insulin Pump Issues

    Medical device manufacturer Medtronic PLC has escaped proposed investor class action claims it concealed issues affecting a certain insulin pump it makes, hurting investors after its trading prices fell when the company disclosed it had received a related warning letter from the U.S. Food and Drug Administration.

  • October 01, 2025

    DHS Accused Of Illegal Data Use In Voter Purge Lawsuit

    The League of Women Voters and a group of naturalized U.S. citizens are suing to stop the Trump administration's pooling of immigrant personal data across federal agencies into centralized databases at the U.S. Department of Homeland Security, saying states are using the "unreliable" systems to purge voter rolls.

  • October 01, 2025

    Texas Judge Sends Mifepristone Challenge To Missouri Court

    A closely watched challenge to federal approvals for the abortion medication mifepristone is moving from Texas to Missouri after a federal judge found the plaintiffs remaining in the litigation have no connection to the Lone Star State.

  • October 01, 2025

    Trans Athlete Fights To Halt High Court Review Of Idaho Ban

    Lindsay Hecox told the U.S. Supreme Court on Tuesday her case challenging an Idaho state law banning transgender athletes such as herself is now moot because she has dropped her litigation, providing "no basis" to proceed with a review, contrary to the state's arguments saying otherwise.

  • October 01, 2025

    3rd Circ. Hints Forum Query Premature In $139M Award Row

    A Third Circuit panel wondered Wednesday whether a Delaware court asked the right question before it concluded that it lacked jurisdiction over a Chilean company's quest to rope an Italian contractor's U.S. assets into a bid to collect on a $139 million arbitration award.

  • October 01, 2025

    Ga. Atty DQ'd From 'Extremely Weird' Pharma Fraud Case

    A Georgia federal judge said Wednesday she intends to disqualify a prominent defense attorney from representing a man charged with lying to investigators amid a criminal fraud probe into his employer, Hi-Tech Pharmaceuticals Inc., but would allow the company to continue footing his legal bills as he seeks new counsel.

  • October 01, 2025

    Cozen O'Connor Adds Healthcare Litigator To Philly Office

    An attorney with more than three decades of experience representing healthcare providers in litigation matters has recently moved his practice to Cozen O'Connor's Philadelphia shop.

  • October 01, 2025

    Weil, Morgan Lewis Steer Up To $900M Biopharma Purchase

    Biopharmaceutical company Halozyme Therapeutics Inc., led by Weil Gotshal & Manges LLP, on Wednesday announced plans to buy fellow biopharma company Elektrofi Inc., advised by Morgan Lewis & Bockius LLP, for up to $900 million.

  • October 01, 2025

    Ga. Panel Backs Doctors In Brothers' Suit Over Mom's Death

    A Georgia appeals panel has sided with a pair of doctors and their employers in a suit by brothers alleging a failure to quickly diagnose their mother before she was paralyzed, saying the trial court did not incorrectly instruct the jury on the definition or application of gross negligence.

  • September 30, 2025

    McKinsey Trims Endo Suit But Can't Nix Indemnification Claim

    A New York bankruptcy judge trimmed an adversary suit Monday claiming McKinsey & Co. Inc. should pay at least $1.5 billion to cover costs bankrupt pharmaceutical developer Endo International racked up defending against opioid claims, tossing nearly all allegations with leave to amend, but greenlighting an indemnification claim.

  • September 30, 2025

    Feds Finalize Rules To Speed H-2A Filing, Limit Some Wages

    The Trump administration finalized two separate rules on Tuesday aimed at streamlining the H-2A temporary visa process for seasonal farmworkers, one allowing employers to file petitions earlier and another revising annual wage hikes for certain agricultural jobs.

  • September 30, 2025

    Ill. Doctor Gets Two Years' Probation For $4M Medicare Fraud

    A former doctor who admitted to submitting more than $4 million in false Medicare claims was sentenced to two years of probation Tuesday by an Illinois federal judge who sought to honor the ex-physician's cooperation in prosecutors' efforts to pursue other allegedly culpable defendants in different jurisdictions.

  • September 30, 2025

    Texas Court Upends $13M Home Care Car-Train Crash Verdict

    A Texas appeals court has vacated a $13 million verdict against a home care provider over a car-train crash that killed one of its clients and injured his wife, saying the trial court instructed the jury incorrectly and the evidence did not show that the provider's employee was acting in the course and scope of her employment.

  • September 30, 2025

    Pharmacist Gets 35 Months For 'Insidious' $11M Drug Scheme

    A pharmacist was sentenced on Tuesday to 35 months in prison for his role in a plot to file fraudulent prescriptions for specialty drugs that were later sold for profit, costing Medicare and an insurer at least $5.6 million and earning the pharmacist and his wife more than $11 million.

  • September 30, 2025

    Blue Cross Insurers Sanctioned For 2-Year Discovery Drawout

    An Illinois federal judge has ordered a host of Blue Cross and Blue Shield insurers to pay the fees and costs Walgreens incurred in an overbilling suit while helping to work through discovery production, which took two years to remediate with a special master.

  • September 30, 2025

    Nevada Hospital Nets $510M Verdict In Staff Poaching Suit

    A Nevada hospital won a jury award of more than $510 million in its lawsuit accusing Universal Health Services of raiding its staff and swiping its trade secrets during the COVID-19 pandemic.

  • September 30, 2025

    HHS Moves To Suspend Harvard From Funding

    The civil rights office at the U.S. Department of Health and Human Services is moving to cut off Harvard University from future funding, a maneuver legal experts say could stymie healthcare and biomedical research.

  • September 30, 2025

    Judge Ends Challenge To Mich. Abortion Rights Amendment

    A federal judge tossed a challenge to Michigan's voter-approved constitutional right to an abortion on Tuesday because abortion opponents had not shown they were personally harmed by the amendment.

  • September 30, 2025

    Wis. Legislators Trying Again To Legalize Medical Cannabis

    Republican state lawmakers in Wisconsin have introduced a bill to legalize smokeless cannabis products for medical use, more than a year and a half after a similar proposal died.

  • September 30, 2025

    Judge Freezes Chinese Cos.' Assets In X-Ray IP Suit

    Two Chinese companies were barred from doing business in the United States and had their U.S.-based assets frozen by a Chicago federal judge until they comply with an earlier injunction order, with the judge stopping short of referring the pair and two of their executives for criminal contempt charges.

  • September 30, 2025

    Hospital Urges Justices To Review 7th Circ. Medicaid Ruling

    A Chicago hospital urged the U.S. Supreme Court to take up its petition for review of a Seventh Circuit ruling that had shut down its suit against the state of Illinois seeking enforcement of timely Medicaid payments, saying it's an "excellent opportunity" to address "resulting uncertainties" after a recent ruling against Planned Parenthood.

  • September 30, 2025

    Health Aide's Overtime Case Ends After Settlement Rewrite

    A Connecticut federal judge has approved a home healthcare aide's $60,000 settlement in an overtime wage lawsuit after the parties removed a contentious clause that would have barred the worker from seeking future employment with the same company, court records show.

  • September 30, 2025

    FCA Suit Tainted By Expert's AI 'Hallucination' Gets Dismissed

    A False Claims Act suit rocked by allegations of AI-generated hallucinations in an expert's report ended Tuesday after the federal government joined the case and quickly urged a Utah federal judge to throw it out.

Expert Analysis

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • High Court E-Cig Ruling Opens Door For FDA Challenges

    Author Photo

    There will likely be more challenges to marketing denial orders brought before the Fifth Circuit following the Supreme Court's recent ruling in U.S. Food and Drug Administration v. R.J. Reynolds Vapor Co., where litigants have generally had greater success, say attorneys at Troutman Pepper.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

  • Series

    Coaching Cheerleading Makes Me A Better Lawyer

    Author Photo

    At first glance, cheerleading and litigation may seem like worlds apart, but both require precision, adaptability, leadership and the ability to stay composed under pressure — all of which have sharpened how I approach my work in the emotionally complex world of mass torts and personal injury, says Rashanda Bruce at Robins Kaplan.

  • 7 Ways To Fetch Patents In The World Of Working Animals

    Author Photo

    Though developers rarely file patents related to working animals, and animal training techniques are generally considered unpatentable, certain aspects of training and developing animals may be ripe for patent protection, say Matthew Avery at Baker Botts, Makenzi Galvan at Perkins Coie and Lute Yang at Orrick.

  • 9th Circ.'s Kickback Ruling Strengthens A Prosecutorial Tool

    Author Photo

    The Ninth Circuit's decision last month in U.S. v. Schena, interpreting the Eliminating Kickbacks in Recovery Act to prohibit kickback conduct between the principal and individuals who do not directly interact with patients, serves as a wake-up call to the booming clinical laboratory testing industry, say attorneys at Kendall Brill.

  • Series

    Law School's Missed Lessons: How To Make A Deal

    Author Photo

    Preparing lawyers for the nuances of a transactional practice is not a strong suit for most law schools, but, in practice, there are six principles that can help young M&A lawyers become seasoned, trusted deal advisers, says Chuck Morton at Venable.

  • 4th Circ. Clarifies Employer Duties For ADA Accommodations

    Author Photo

    The Fourth Circuit's recent decision in Tarquinio v. Johns Hopkins indicates that an employer's obligation to provide accommodations under the Americans with Disabilities Act may never arise if an employee obstructs the process, underscoring that ADA protections depend on cooperation between both parties, say attorneys at Hunton.

  • From Clerkship To Law Firm: 5 Transition Tips For Associates

    Excerpt from Practical Guidance
    Author Photo

    Transitioning from a judicial clerkship to an associate position at a law firm may seem daunting, but by using knowledge gained while clerking, being mindful of key differences and taking advantage of professional development opportunities, these attorneys can flourish in private practice, say attorneys at Lowenstein Sandler.

  • Opinion

    Fla. Misses Opportunity To Rectify Wrongful Death Damages

    Author Photo

    Florida Gov. Ron DeSantis' recent veto of a bill that would have removed certain arbitrary and unfair prohibitions on noneconomic wrongful death damages in medical negligence cases highlights the urgent need for reforms to current state law, say attorneys at Farah & Farah.

  • Budget Act Should Boost Focus On Trade Compliance

    Author Photo

    Passage of the One Big Beautiful Budget Act, coupled with recent U.S. Department of Justice statements that it will use the False Claims Act aggressively to pursue trade, tariff and customs fraud, marks a sharp increase in trade-related enforcement risk, say attorneys at Debevoise.

  • Associates Can Earn Credibility By Investing In Relationships

    Author Photo

    As the class of 2025 prepares to join law firms this fall, new associates must adapt to office dynamics and establish credible reputations — which require quiet, consistent relationship-building skills as much as legal acumen, says Kyle Forges at Bast Amron.

  • New Colo. Teen Privacy Rules Signal National Regulatory Shift

    Author Photo

    Recently released proposed rule amendments to the Colorado Privacy Act that would create some of the most robust protections for minors' online data in the U.S. reflect an ongoing trend of states taking steps to extend privacy protection for their residents, complicating the compliance burden for companies, say attorneys at Morgan Lewis.

  • A Shifting Trend In FDA Form 483 Disclosure Obligations

    Author Photo

    A New York federal court's Checkpoint Therapeutics decision extends a recent streak of dismissals of securities class actions alleging that pharmaceutical companies failed to disclose U.S. Food and Drug Administration Form 483 inspection reports, providing critical guidance for companies during the FDA approval process, say attorneys at Alston & Bird.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.